HAS-BLED Versus ATRIA Risk Scores for Intracranial Hemorrhage in Patients Receiving Thrombolytics for Pulmonary Embolism

Journal of the American College of Cardiology

Volumn 67, Issue 24, 2016, Pages 2904-2905

  Chatterjee, Saurav ^a   Lip, Gregory Y H ^a   Giri, Jay ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT; ANTICOAGULANT AGENT;

ADULT; AGE; ALCOHOL CONSUMPTION; ANEMIA; BLEEDING; BLOOD CLOTTING DISORDER; BRAIN HEMORRHAGE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; DRUG USE; END STAGE RENAL DISEASE; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; HYPERTENSION; KIDNEY DYSFUNCTION; LENGTH OF STAY; LETTER; LIVER DYSFUNCTION; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; AGED; METHODOLOGY; MIDDLE AGED; PROCEDURES;

AGED; ANTICOAGULANTS; FEMALE; HUMANS; INTRACRANIAL HEMORRHAGES; MALE; MIDDLE AGED; PULMONARY EMBOLISM; RESEARCH DESIGN; RISK ASSESSMENT; THROMBOLYTIC THERAPY;

EID: 84979642939     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2016.03.577     Document Type: Letter

References (5)

1. 1 Chatterjee, S., Chakraborty, A., Weinberg, I., et al. Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis. JAMA 311 (2014), 2414–2421.
2. 2 Healthcare Cost and Utilization Project (HCUP). HCUP Databases. July 2008. 2008, Agency for Healthcare Research and Quality, Rockville, MD Available at: http://www.hcup-us.ahrq.gov/nisoverview.jsp Accessed September 1, 2015.
3. 3 Deyo, R.A., Cherkin, D.C., Ciol, M.A., Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45 (1992), 613–619.
4. 4 Pisters, R., Lane, D.A., Nieuwlaat, R., et al. A novel user-friendly score (HAS-BLED) to assess one-year risk of major bleeding in atrial fibrillation patients: the Euro Heart Survey. Chest 138 (2010), 1093–1100.
5. 5 Fang, M.C., Go, A.S., Chang, Y., et al. A new risk scheme to predict warfarin-associated hemorrhage: the ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) study. J Am Coll Cardiol 58 (2011), 395–401.